unknown
Stage
About
Coherent Biopharma develops bi-targeting XDC (conjugate) technology to create novel drug candidates addressing unmet medical needs in oncology and other diseases.
Explore Coherent Biopharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.